Farmakokemiska

Farmakokemiska is a Swedish company focused on the development and manufacturing of active pharmaceutical ingredients (APIs). Founded in 1981, the company is based in Uppsala, Sweden. Farmakokemiska specializes in complex organic synthesis, often involving multi-step processes to produce highly potent and specialized pharmaceutical compounds. Their expertise lies in producing APIs for various therapeutic areas, including oncology, central nervous system disorders, and cardiovascular diseases.

The company operates a modern manufacturing facility that adheres to strict Good Manufacturing Practice (GMP) guidelines, ensuring the quality and safety of its products. Farmakokemiska's services include process development, scale-up, and commercial manufacturing of APIs. They work with pharmaceutical companies globally, providing custom synthesis and contract manufacturing services. Their commitment to research and development allows them to tackle challenging chemical syntheses and to continuously improve their manufacturing processes. Farmakokemiska emphasizes sustainability in its operations, aiming to minimize environmental impact through efficient resource utilization and waste reduction. The company plays a role in the global pharmaceutical supply chain by providing essential ingredients for life-saving medications.